UNSPSC 51162314: Acetaminophen/chlorpheniramine/phenylpropanolamine/phenyltoloxamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162314 Acetaminophen/chlorpheniramine/phenylpropanolamine/phenyltoloxamine is a Commodity code that captures pharmaceutical products and related medical supplies procured by state and local health and correctional agencies. The recent state and local opportunities tagged to this code reflect a broader pattern of procurement for pharmaceutical solutions, intravenous products, and emergency medical supplies rather than the specific combination drug named in the code's title. State and local governments soliciting under this code include state departments of corrections, county health departments, and public health agencies. The work involves sourcing parenteral nutrition solutions, intravenous medications, naloxone, and pharmaceutical deactivation systems for distribution to correctional facilities, community health programs, and emergency response initiatives.

The Washington State Department of Corrections and Seminole County, Florida represent the issuing bodies visible in recent activity. Washington State issued an RFQ (RFQQK13020) on September 8, 2026, due October 7, 2026, for parenteral products, services, and equipment to supply eight correctional facilities across three regions, with DOC encouraging small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation and anticipating awards to up to three bidders per region. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Recent activity concentrates in the Pacific Northwest and Southeast regions, with Washington and Florida representing the visible jurisdictions in the current procurement window.